Given the formidable challenges that AKI poses, a comprehensive understanding of both COX7A2L and TCF4 emerges as a pivotal step, potentially revolutionizing diagnostic precision and therapeutic interventions. This evidence concerns the gene COX7A2L and acute kidney injury.